Aperam SA
MAD:APAM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24.2
35.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
APAM
stock under the Base Case scenario is
66.87
EUR.
Compared to the current market price of 34.6 EUR,
Aperam SA
is
Undervalued by 48%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Aperam SA.
| ZA |
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
|
| BR |
|
Vale SA
BOVESPA:VALE3
|
|
| AU |
|
Fortescue Metals Group Ltd
ASX:FMG
|
|
| AU |
F
|
Fortescue Ltd
XMUN:FVJ
|
|
| US |
|
Nucor Corp
NYSE:NUE
|
|
| LU |
|
ArcelorMittal SA
AEX:MT
|
|
| IN |
|
JSW Steel Ltd
NSE:JSWSTEEL
|
|
| US |
|
Steel Dynamics Inc
NASDAQ:STLD
|
|
| IN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
|
| CN |
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Aperam SA
Balance Sheet Decomposition
Aperam SA
| Current Assets | 2.1B |
| Other Current Assets | 2.1B |
| Non-Current Assets | 3.2B |
| Long-Term Investments | 4m |
| PP&E | 2.2B |
| Intangibles | 511m |
| Other Non-Current Assets | 425m |
| Current Liabilities | 1.1B |
| Accrued Liabilities | 431m |
| Other Current Liabilities | 678m |
| Non-Current Liabilities | 997m |
| Long-Term Debt | 687m |
| Other Non-Current Liabilities | 310m |
Free Cash Flow Analysis
Aperam SA
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Aperam SA
|
Revenue
|
9.3B
EUR
|
|
Operating Expenses
|
-9.3B
EUR
|
|
Operating Income
|
0
EUR
|
|
Other Expenses
|
153m
EUR
|
|
Net Income
|
153m
EUR
|
APAM Profitability Score
Profitability Due Diligence
Aperam SA's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Aperam SA's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
APAM Solvency Score
Solvency Due Diligence
Aperam SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Aperam SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APAM Price Targets Summary
Aperam SA
According to Wall Street analysts, the average 1-year price target for
APAM
is 33.87 EUR
with a low forecast of 25.92 EUR and a high forecast of 45.26 EUR.
Dividends
Current shareholder yield for
APAM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
APAM
stock under the Base Case scenario is
66.87
EUR.
Compared to the current market price of 34.6 EUR,
Aperam SA
is
Undervalued by 48%.